Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for P13 kinase and PKC involvement

Carcinogenesis

Volumn 22, Issue 7, 2001, Pages 1035-1042

  Kermorgant, S ^a   Aparicio, T ^a   Dessirier, V ^a   Lewin, M J M ^a   Lehy, T ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIGEL; MATRIX METALLOPROTEINASE INHIBITOR; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UROKINASE;

ARTICLE; ASSAY; BASEMENT MEMBRANE; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL STIMULATION; COLON CANCER; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME RELEASE; ENZYME SYNTHESIS; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; INHIBITION KINETICS; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR GROWTH; ZYMOGRAPHY;

EID: 0034934354     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/22.7.1035     Document Type: Article

References (43)

1. Cancer invasion and metastases
2. r 72,000 type IV collagenase in human colonic adenocarcinoma
3. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo
4. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases
5. Interleukin 4 inhibits hepatocyte growth factor-induced invasion and migration of colon carcinomas
6. Expression of hepatocyte growth factor and its receptor C-Met, in human digestive tissues and different gastric and colonic cancer cell lines
7. Developmental expression, dynamics of localization and functionality of hepatocyte growth factor and c-Met receptor in human fetal digestive tissues
8. Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas
9. Aberrant expression of c-met mRNA in human gastric carcinomas
10. Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer
11. Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by γ-linolenic acid
12. Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal-adenocarcinoma cells
13. Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration
14. Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural epithelia and induction of rapid wound repair in a transformed model epithelium
15. Hepatocyte growth factor accelerates the wound repair of cultured gastric mucosal cells
16. Hepatocyte growth factor stimulates wound repair of the rabbit esophageal epithelial cells in primary culture
17. Hepatocyte growth factor stimulates invasion across reconstituted basement membranes by a new human small intestinal cell line
18. Transforming growth factor-β and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells
19. Inhibition by platelet-activating factor of Src-and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3′-kinase is a critical mediator of tumor invasion
20. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase
21. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras
22. Activation of the 41/43 kDa mitogen-activated protein kinase signaling pathway is required for hepatocyte growth factor-induced cell scattering
23. c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells
24. Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis
25. Protein kinase c-α activity inversely modulates invasion and growth of intestinal cells
26. A comparative evaluation of various invasion assays testing colon carcinoma cell lines
27. Effects of hepatocyte growth factor (HGF) on human glioma cells in vitro: HGF acts as a motility factor in glioma cells
28. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats
29. Overview of matrix metalloproteinase expression in cultured human cells
30. A rapid in vitro assay for quantitating the invasive potential of tumor cells
31. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor
32. Hepatocyte growth factor stimulates the invasion of gallbladder carcinoma cell lines in vitro
33. Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells
34. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production
35. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion
36. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells
37. Protein kinase Cα modulates growth and differentiation in Caco-2 cells
38. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway
39. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor
40. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast and head and neck carcinomas
41. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation
42. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor-and scatter factor-stimulated invasion of carcinoma cells
43. Specificity and mechanism of action of some commonly used protein kinase inhibitors